Martine Clozel

Martine Clozel is the current EVP and Chief Scientific Officer at Idorsia. Martine previously worked at GlaxoSmithKline as a Senior Sales Executive from February 2008 to June 2021.

Martine Clozel has a Bachelor of Science (B.S.) from Converse University. Martine also has certification from the American Society for Clinical Pathology (ASCP) in MT (ASCP).

They work with Andrew C. Weiss - SVP, Head of Investor Relations & Corporate Communications, Ulrich Mentzel - SVP, Head of Drug Discovery Pharmacology & Preclinical Development, and André C. Muller - EVP, CFO. Martine Clozel reports to Jean-Paul Clozel, CEO.